Economic Implications of Gene Editing
As gene editing transforms healthcare, agriculture, and biotechnology, significant economic shifts are anticipated. The burgeoning gene-editing industry promises substantial job creation in research, clinical applications, agriculture, and bioengineering sectors, driving economic growth and innovation. However, these financial benefits may be unevenly distributed, potentially deepening existing socioeconomic divides.
Wealthier nations and individuals with access to advanced gene-editing therapies could experience disproportionate advantages, exacerbating global economic inequality. Addressing these disparities requires thoughtful policy interventions, strategic investments in education, and international collaboration to ensure gene editing’s economic impacts are inclusive, equitable, and beneficial for all communities worldwide.